Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Allogeneic PB103 (NK Cells) Therapy in Non-small Cell Lung Cancer (NSCLC) Patients
Phase 1
Recruiting
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- Biological: donor-derived NK cell infusion
- First Posted Date
- 2020-11-04
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Precision Biotech Taiwan Corp.
- Target Recruit Count
- 24
- Registration Number
- NCT04616209
- Locations
- 🇨🇳
Tri-Service General Hospital, Taipei city, Taiwan
News
No news found